![]() |
|||||||||
American-Italian Cancer Foundation: Pancreatic Cancer Research Initiative (PCRI)Internal Competition CompletedPrincipal Investigators Selected:
Program SummaryThe American-Italian Cancer Foundation (AICF) has launched a new Pancreatic Cancer Research Initiative (PCRI). Beginning in 2009, scientific researchers from the United States, Italy, and other parts of Europe will be eligible to receive funding for projects of up to three years in basic, translational, or genetic research as it applies to pancreatic cancer. PCRI grants will fund research that shows great promise for translating knowledge gained to prevention or new treatments and, ultimately, for prolonging and enhancing the life of pancreatic cancer patients. Applicants will be encouraged to collaborate with one or more research institutions in Italy or other parts of Europe; viable partner institutions may hail from any country in the European Union. Applications that include a collaborative aspect will be given special consideration, as will genetic research projects in pancreatic cancer that will be conducted in Italy. $225,000 will be available in Spring 2009 for one or more awards. A maximum of 20 percent in indirect costs will be allowed. Grants will be awarded each year for a one-year duration that begins on September 1. Assuming that progress is satisfactory and that there is continued need, grants may be renewed for at least a second year. UIC is restricted to one application. Additional Information Deadlines
Letter of Intent Instructions
LOI form: http://tigger.uic.edu/depts/ovcr/research/funding/forms/0600.doc Depending upon the number of LOIs submitted, OVCR might be required to facilitate an internal peer review process to select UIC’s submission(s) to this program. White paper instructions will be issued to those submitting LOIs, if necessary. Please contact Chang Lee at clee10@uic.edu or 6-1961 with any questions. |
|||||||||
|
|||||||||